SG10201600303WA - Methods Of Synthesizing A Prostacyclin Analog - Google Patents

Methods Of Synthesizing A Prostacyclin Analog

Info

Publication number
SG10201600303WA
SG10201600303WA SG10201600303WA SG10201600303WA SG10201600303WA SG 10201600303W A SG10201600303W A SG 10201600303WA SG 10201600303W A SG10201600303W A SG 10201600303WA SG 10201600303W A SG10201600303W A SG 10201600303WA SG 10201600303W A SG10201600303W A SG 10201600303WA
Authority
SG
Singapore
Prior art keywords
synthesizing
methods
prostacyclin analog
prostacyclin
analog
Prior art date
Application number
SG10201600303WA
Other languages
English (en)
Inventor
Kirk William Hering
Gilles Chambournier
Gregory William Endres
Victor Fedij
Thomas James Ii Krell
Hussein Mahmoud Mahmoud
Original Assignee
Cayman Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cayman Chemical Co Inc filed Critical Cayman Chemical Co Inc
Publication of SG10201600303WA publication Critical patent/SG10201600303WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/44Separation; Purification; Stabilisation; Use of additives by treatments giving rise to a chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/14Benz[f]indenes; Hydrogenated benz[f]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SG10201600303WA 2012-12-07 2013-12-06 Methods Of Synthesizing A Prostacyclin Analog SG10201600303WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261734672P 2012-12-07 2012-12-07
US201361777882P 2013-03-12 2013-03-12

Publications (1)

Publication Number Publication Date
SG10201600303WA true SG10201600303WA (en) 2016-02-26

Family

ID=49881039

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201504430TA SG11201504430TA (en) 2012-12-07 2013-12-06 Methods of synthesizing a prostacyclin analog
SG10201600303WA SG10201600303WA (en) 2012-12-07 2013-12-06 Methods Of Synthesizing A Prostacyclin Analog

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201504430TA SG11201504430TA (en) 2012-12-07 2013-12-06 Methods of synthesizing a prostacyclin analog

Country Status (20)

Country Link
US (4) US20150315114A1 (enExample)
EP (2) EP2928858B1 (enExample)
JP (2) JP6342414B2 (enExample)
KR (1) KR20150091170A (enExample)
CN (3) CN107098925B (enExample)
AU (2) AU2013355130B2 (enExample)
BR (1) BR112015013085A2 (enExample)
CA (1) CA2893604A1 (enExample)
CL (1) CL2015001535A1 (enExample)
DK (1) DK2928858T3 (enExample)
EA (1) EA034309B1 (enExample)
ES (1) ES2664026T3 (enExample)
IL (1) IL239172B (enExample)
MX (2) MX369094B (enExample)
NZ (1) NZ708130A (enExample)
PE (1) PE20160090A1 (enExample)
PH (2) PH12015501258B1 (enExample)
SG (2) SG11201504430TA (enExample)
TW (1) TWI634104B (enExample)
WO (1) WO2014089385A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2928858T3 (en) * 2012-12-07 2018-02-19 Cayman Chemical Co Inc METHODS OF SYNTHESIS OF A PROSTACYCLINE ANALOGUE
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
CA2930574A1 (en) * 2013-11-13 2015-05-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog
HU231186B1 (hu) 2014-10-08 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás treprostinil és sói előállítására
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
EP3515430A1 (en) 2016-09-26 2019-07-31 United Therapeutics Corporation Treprostinil prodrugs
EP3498283A1 (en) 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
HU231296B1 (hu) * 2018-03-09 2022-09-28 Chinoin Zrt Eljárás treprostinil-dietanol-amin só B polimorf formájának előállítására
JP6503508B2 (ja) * 2018-08-03 2019-04-17 Jxtgエネルギー株式会社 テトラカルボン酸二無水物、ポリイミド前駆体樹脂、ポリイミド、ポリイミド前駆体樹脂溶液、ポリイミド溶液及びポリイミドフィルム
CA3149358A1 (en) 2019-08-23 2021-03-04 United Therapeutics Corporation Treprostinil prodrugs
IL296567A (en) 2020-04-17 2022-11-01 United Therapeutics Corp Terfostinil for use in the treatment of interstitial lung disease
US11793780B2 (en) 2020-06-09 2023-10-24 United Therapeutics Corporation Prodrugs of treprosiinil
KR20220030006A (ko) 2020-09-02 2022-03-10 바이오플러스 주식회사 미용 조성물을 포함하는 마스크 및 그 제조 방법
CN117062605A (zh) 2020-12-14 2023-11-14 联合治疗公司 使用曲前列环素前药治疗疾病的方法
CA3209987A1 (en) 2021-03-03 2022-09-09 Hitesh Batra A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
US11884640B2 (en) * 2021-06-02 2024-01-30 Chirogate International Inc. Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom
US11884613B2 (en) * 2022-05-05 2024-01-30 Chirogate International Inc. Processes and intermediates for the preparation of carbaprostacyclin analogues

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
CA2039857A1 (en) * 1990-04-26 1991-10-27 Wilfred Po-Sum Shum Process for producing epoxyalcohols of high optical purity
US6441245B1 (en) * 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6700025B2 (en) * 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
CA2959852A1 (en) * 2003-05-22 2005-01-27 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
EP2177526A4 (en) * 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
EP2252570B1 (en) 2007-12-17 2017-04-05 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin ®
WO2009158010A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Prostacyclin analogs
WO2010039531A1 (en) * 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Therapeutic compounds
CN101891596B (zh) * 2009-05-22 2013-12-11 上海天伟生物制药有限公司 一种化合物及其制备方法和用途
EP2576492B1 (en) 2010-06-03 2017-09-20 United Therapeutics Corporation Treprostinil production
CA2710726C (en) * 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein
EP2622354A1 (en) 2010-10-01 2013-08-07 Rigshospitalet Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
US8865898B2 (en) * 2010-11-30 2014-10-21 Japan Science And Technology Agency Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
US8524939B2 (en) 2011-08-24 2013-09-03 Chirogate International Inc. Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
DK2928858T3 (en) * 2012-12-07 2018-02-19 Cayman Chemical Co Inc METHODS OF SYNTHESIS OF A PROSTACYCLINE ANALOGUE
CA2930574A1 (en) * 2013-11-13 2015-05-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog

Also Published As

Publication number Publication date
AU2013355130B2 (en) 2018-06-21
CN107098925B (zh) 2019-09-13
CA2893604A1 (en) 2014-06-12
JP2018162250A (ja) 2018-10-18
PH12018500562A1 (en) 2019-03-04
EP2928858B1 (en) 2018-01-31
IL239172B (en) 2020-01-30
US20200002261A1 (en) 2020-01-02
AU2018233009B2 (en) 2020-01-23
MX2019009102A (es) 2019-09-16
US20170297995A1 (en) 2017-10-19
EP2928858A2 (en) 2015-10-14
US9908834B2 (en) 2018-03-06
NZ708130A (en) 2020-01-31
SG11201504430TA (en) 2015-07-30
IL239172A0 (en) 2015-07-30
EA201591093A1 (ru) 2015-09-30
PH12015501258A1 (en) 2015-08-17
EP3398931B1 (en) 2020-04-08
HK1212323A1 (en) 2016-06-10
PE20160090A1 (es) 2016-02-20
MX369094B (es) 2019-10-29
JP6342414B2 (ja) 2018-06-13
US10450257B2 (en) 2019-10-22
WO2014089385A2 (en) 2014-06-12
CN107098925A (zh) 2017-08-29
PH12015501258B1 (en) 2015-08-17
AU2018233009A1 (en) 2018-10-18
EP3398931A1 (en) 2018-11-07
DK2928858T3 (en) 2018-02-19
TW201422577A (zh) 2014-06-16
MX2015006972A (es) 2016-02-11
CL2015001535A1 (es) 2016-01-15
BR112015013085A2 (pt) 2017-07-11
AU2013355130A1 (en) 2015-06-11
CN104837806A (zh) 2015-08-12
US20180141889A1 (en) 2018-05-24
KR20150091170A (ko) 2015-08-07
TWI634104B (zh) 2018-09-01
ES2664026T3 (es) 2018-04-18
EA034309B1 (ru) 2020-01-27
WO2014089385A3 (en) 2014-08-28
CN110590547A (zh) 2019-12-20
US20150315114A1 (en) 2015-11-05
JP2016504303A (ja) 2016-02-12

Similar Documents

Publication Publication Date Title
SG10201600303WA (en) Methods Of Synthesizing A Prostacyclin Analog
IL268953B (en) A process to form cycloalkylcarboxamido indole compounds
IL262055B (en) Synthesis of lactams
PL2858493T3 (pl) Synteza MOF
IL256533B (en) A method for the production of inganol-3-englate
PT2875062T (pt) Processo de síntese de poliarilétercetonas
IL221170A0 (en) Processes of synthesizing dihydropyridophthalazinone derivatives
GB201008826D0 (en) Production of metabolites
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
GB201004096D0 (en) Production of polyhydroalkanoates
PL2732707T3 (pl) Sposób wytwarzania kompozycji zawierającej kazeinomakropeptyd
IL226677A (en) Beta-amyloid production compounds
LU92341B1 (en) Method of producing a shaped component
GB2508411B (en) Speech synthesis
IL222474A0 (en) Method of synthesis
IL241042B (en) Methods for the synthesis of a difluorolactam analog
GB201216782D0 (en) Synthesis of MOFs
IL233446A0 (en) Polymorphic forms of paramphenel
ZA201208995B (en) Method of synthesis
ZA201500402B (en) Methods of making flexible containers
PL118707U1 (pl) Zestaw obudowy podporowo-kotwiowej chodnika
GB201105866D0 (en) This is about me